Commentary: pT3N2 non–small cell lung cancer: A heterogenous disease treated with homogenous therapy

Research output: Contribution to journalEditorial

Original languageEnglish
Pages (from-to)393-394
Number of pages2
JournalJTCVS Open
Volume10
DOIs
StatePublished - Jun 2022

Cite this